Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07167069 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

India HIV-CervCa Project

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Primary completion date changed from estimate of May 2026 to Sep 1, 2026 · Eligibility criteria expanded, about 5 words Show 2 more changesShow less
    • Primary completion date changed from estimate of May 2026 to Sep 1, 2026
    • Eligibility criteria expanded, about 5 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators propose to prospectively study the difference in treatment (CTRT) completion and toxicities between HIV positive and HIV negative women in India with locally advanced cervical cancer receiving CTRT.
Trial Details
NCT Number NCT07167069
Lead Sponsor Abramson Cancer Center at Penn Medicine
Collaborators: Tata Memorial Hospital, National Institute of Allergy and Infectious Diseases (NIAID)
Conditions HIV Positive, HIV Negative, Cervical Cancer
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov